Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 May 2019 10:46

RNS Number : 7376X
Reckitt Benckiser Group PLC
01 May 2019
 

 

Sara Mathew to join RB Board, bringing deep knowledge of consumer goods and digital technologies

 

1 May 2019, Slough UK - Reckitt Benckiser Group plc is pleased to announce the appointment of Sara Mathew to the Board as a non-executive director, effective 1 July 2019. She will also join the Audit Committee of the Board at the same time.

Most recently Ms Mathew was Chairman and Chief Executive Officer of Dun & Bradstreet, a company providing commercial data, analytics and insights for businesses. In this role, she led a transformation of the company into an innovative digital enterprise, leveraging technology to enhance both data quality and coverage. Prior to this role, Ms Mathew served as President and Chief Operating Officer, and before that, she was Chief Financial Officer.

Prior to her career at Dun & Bradstreet, Ms Mathew had an 18-year career at Procter & Gamble serving as CFO of the Baby Care and Paper Products businesses and Vice President of Finance in Asia.

Ms Mathew has extensive board experience across a number of industries including healthcare, consumer products and financial services. Previously, she served on the boards of Shire Pharmaceuticals, Campbell Soup Company and Avon. Currently Ms Mathew is on the board of State Street Bank and is Chair of the Board of Freddie Mac, the US home loan company.

Ms Mathew received her undergraduate degree from the University of Madras in Chennai, India and holds a Master of Business Administration in marketing and finance from Xavier University in Cincinnati, Ohio.

Commenting on the appointment, Chris Sinclair, Chairman of the Board said "I am delighted that Sara has agreed to join the Board. She has extensive experience with consumer goods products, digital technologies and healthcare and has led strategic and digital transformations. Sara will bring great insight to the Board and we welcome her appointment."

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Sara Mathew's appointment.

About RB

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes. 

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. 

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide. 

For more information visit www.rb.com

 *RB is the trading name of the Reckitt Benckiser group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

For further information, please contact:

Reckitt Benckiser +44 (0)1753 217800

Patty O'Hayer, James Fearnley-Marr

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUWCAUPBUBG
Date   Source Headline
31st Mar 202110:00 amRNSRB rebrands as Reckitt
26th Mar 202112:30 pmRNSDirector/PDMR Shareholding
17th Mar 20213:00 pmRNSDirector/PDMR Shareholding
4th Mar 20212:30 pmRNSDirector/PDMR Shareholding
3rd Mar 202110:00 amRNSDirector/PDMR Shareholding
1st Mar 20213:00 pmRNSDirector/PDMR Shareholding
1st Mar 20212:16 pmRNSTotal Voting Rights
25th Feb 20213:20 pmRNSDirector/PDMR Shareholding
24th Feb 20217:01 amRNSDisposal
24th Feb 20217:01 amRNSAcquisition
24th Feb 20217:00 amRNSFinal Results
1st Feb 202111:42 amRNSTotal Voting Rights
4th Jan 202112:39 pmRNSTotal Voting Rights
30th Dec 20209:21 amRNSTR-1: Notification of major holdings
17th Dec 202010:45 amRNSDirectorate Change
1st Dec 202011:30 amRNSTotal Voting Rights
25th Nov 202011:30 amRNSDirector/PDMR Shareholding
23rd Nov 20204:30 pmRNSDirector/PDMR Shareholding
2nd Nov 202011:10 amRNSTotal Voting Rights
21st Oct 20202:00 pmRNSDirector/PDMR Shareholding
20th Oct 20204:35 pmRNSPrice Monitoring Extension
20th Oct 20207:00 amRNS3rd Quarter Results
7th Oct 20203:00 pmRNSDirector Declaration
5th Oct 20204:00 pmRNSDirector/PDMR Shareholding
1st Oct 20202:34 pmRNSDirector/PDMR Shareholding
1st Oct 202011:38 amRNSTotal Voting Rights
1st Sep 202010:22 amRNSTotal Voting Rights
26th Aug 20201:05 pmRNSDisclosure of rights attached to equity shares
25th Aug 20204:00 pmRNSDirector/PDMR Shareholding
3rd Aug 202012:08 pmRNSTotal Voting Rights
28th Jul 20207:00 amRNSHalf-year Report
1st Jul 20209:17 amRNSTotal Voting Rights
30th Jun 20205:00 pmRNSDirector Declaration
23rd Jun 202010:00 amRNSDirectorate Change
5th Jun 20204:30 pmRNSDirector/PDMR Shareholding
1st Jun 202011:01 amRNSTotal Voting Rights
29th May 20204:41 pmRNSSecond Price Monitoring Extn
29th May 20204:36 pmRNSPrice Monitoring Extension
29th May 20204:30 pmRNSDirector/PDMR Shareholding
29th May 202012:20 pmRNSDirector/PDMR Shareholding
28th May 20202:29 pmRNSDirector/PDMR Shareholding
13th May 20205:46 pmRNSDirector/PDMR Shareholding
13th May 20202:07 pmRNSPublication of Offering Memorandum
12th May 20206:01 pmRNSIssue of Debt
12th May 20204:55 pmRNSResult of AGM
12th May 20204:15 pmRNSDirectorate Change
4th May 20202:10 pmRNSDirector/PDMR Shareholding
1st May 20204:41 pmRNSDirector/PDMR Shareholding
1st May 202011:38 amRNSTotal Voting Rights
30th Apr 20207:00 amRNSQ1 2020 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.